Mavacamten will lessen the extent or effect of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may minimize systemic exposures of ethinyl estradiol and progestin, which may cause contraceptive failure or a rise in breakthrough bleeding. fedratinib will https://whitneyv987fse1.westexwiki.com/user